Codexis, Inc.
LSE: 0I0X.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alison Moore
- Employees
- 188
- Headquarters
- Redwood City, United States
- IPO year
- 2018
- Market cap
- $246.5M
- Website
- https://www.codexis.com
Loading 0I0X…
Loading profile data…Frequently asked questions about 0I0X
What does Codexis, Inc. (0I0X.L) do?
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
Where does 0I0X.L trade?
Codexis, Inc. (0I0X.L) trades on the London Stock Exchange.
What sector is 0I0X.L in?
Codexis, Inc. (0I0X.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Codexis, Inc.?
Alison Moore is the chief executive officer of Codexis, Inc. (0I0X.L).
Where is Codexis, Inc. headquartered?
Codexis, Inc. is headquartered in United States.
Does 0I0X.L pay a dividend?
Codexis, Inc. (0I0X.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0I0X.L go public?
Codexis, Inc. (0I0X.L) completed its initial public offering in 2018.